Search Results - Sadar, Marianne D

Refine Results
  1. 1
    Small Molecule Inhibitors Targeting the ‘Achilles’ Heel of Androgen Receptor Activity

    Small Molecule Inhibitors Targeting the ‘Achilles’ Heel of Androgen Receptor Activity by Sadar, Marianne D.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

    Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor by Sadar, Marianne D

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer

    Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer by Comuzzi, Barbara, Sadar, Marianne D

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Androgen receptor and its splice variants in prostate cancer

    Androgen receptor and its splice variants in prostate cancer by Haile, Simon, Sadar, Marianne D.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens

    Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens by Ito, Yusuke, Sadar, Marianne D

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

    Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer? by Hirayama, Yukiyoshi, Sadar, Marianne D.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic

    Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic by Imamura, Yusuke, Sadar, Marianne D

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens

    14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens by Quayle, Steven N., Sadar, Marianne D.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Large scale phosphoproteome analysis of LNCaP human prostate cancer cells

    Large scale phosphoproteome analysis of LNCaP human prostate cancer cells by Myung, Jae-Kyung, Sadar, Marianne D

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

    Non-Genomic Actions of the Androgen Receptor in Prostate Cancer by Leung, Jacky K., Sadar, Marianne D.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation

    Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation by Obst, Jon K., Sadar, Marianne D.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Keys to unlock androgen receptor translocation

    Keys to unlock androgen receptor translocation by Tien, Amy H., Sadar, Marianne D.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the Treatment of Androgen Receptor–positive Prostate and Breast Cancers

    Cyclin-dependent Kinase 4/6 Inhibitor Palbociclib in Combination with Ralaniten Analogs for the Treatment of Androgen Receptor–positive Prostate and Breast Cancers by Tien, Amy H., Sadar, Marianne D.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Crosstalk between the Androgen Receptor and β-Catenin in Castrate Resistant Prostate Cancer

    Crosstalk between the Androgen Receptor and β-Catenin in Castrate Resistant Prostate Cancer by Wang, Gang, Wang, Jun, Sadar, Marianne D.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells

    FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells by Haile, Simon, Lal, Aaron, Myung, Jae-Kyung, Sadar, Marianne D.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Isolation and Characterization of Castration-Resistant Prostate Cancer LNCaP95 Clones

    Isolation and Characterization of Castration-Resistant Prostate Cancer LNCaP95 Clones by Leung, Jacky K., Tam, Teresa, Wang, Jun, Sadar, Marianne D.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Androgen receptor decoy molecules block the growth of prostate cancer

    Androgen receptor decoy molecules block the growth of prostate cancer by Quayle, Steven N., Mawji, Nasrin R., Wang, Jun, Sadar, Marianne D.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    N‐terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy

    N‐terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy by Martin, Sarah K., Banuelos, Carmen A., Sadar, Marianne D., Kyprianou, Natasha

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer

    Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer by Hirayama, Yukiyoshi, Tam, Teresa, Jian, Kunzhong, Andersen, Raymond J., Sadar, Marianne D.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer

    Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer by Antonarakis, Emmanuel S., Chandhasin, Chandtip, Osbourne, Erica, Luo, Jun, Sadar, Marianne D., Perabo, Frank

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: